Impact of Imiglucerase Supply Constraint on the Therapeutic Management and Course of Disease in French Patients With Gaucher Disease Type 1

Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/s13023-015-0275-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparative Therapeutic Effects of Velaglucerase Alfa and Imiglucerase in a Gaucher Disease Mouse Model

PLoS ONE
Multidisciplinary
2010English

Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2017English

Long-Term Clinical Outcomes in Type 1 Gaucher Disease Following 10 Years of Imiglucerase Treatment

Journal of Inherited Metabolic Disease
Genetics
2012English

High Incidence of Cholesterol Gallstone Disease in Type 1 Gaucher Disease: Characterizing the Biliary Phenotype of Type 1 Gaucher Disease

Journal of Inherited Metabolic Disease
Genetics
2010English

The Clinical Management of Type 2 Gaucher Disease

Molecular Genetics and Metabolism
GeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2015English

Review of the Safety and Efficacy of Imiglucerase Treatment of Gaucher Disease

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Russian Pediatric Experience on Assessing the Effectiveness of Imiglucerase for Long-Term Enzyme Replacement Therapy of Gaucher Disease Type 1 in Children

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
Medicine
2017English

Endocrine and Metabolic Disorders in Patients With Gaucher Disease Type 1: A Review

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Psy51 - Clinical and Economic Aspects of Enzyme Replacement Therapy in Russian Patients With Gaucher Disease Type 1

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy